Once liver fibrosis progresses to cirrhosis (stage F4), scarring becomes extensive and irreversible. However, even in ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

Aminath Naifa undergoes successful liver transplantation at MIOT International despite rare blood type complication.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

EnteroBiotix to present results from IMPuLCE phase 1b trial of EBX-102 in patients with liver cirrhosis at EASL Congress 2025: Glasgow, Scotland Monday, May 5, 2025, 13:00 Hrs [IS ...